[{"id":"f44f76e4-0ba3-4481-b09e-d12b99a9cec1","acronym":"","url":"https://clinicaltrials.gov/study/NCT05655312","created_at":"2022-12-19T15:59:21.058Z","updated_at":"2024-07-02T16:35:11.693Z","phase":"Phase 1/2","brief_title":"MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma","source_id_and_acronym":"NCT05655312","lead_sponsor":"Perspective Therapeutics","biomarkers":" BRAF","pipe":"","alterations":" ","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e VMT-01"],"overall_status":"Recruiting","enrollment":" Enrollment 52","initiation":"Initiation: 06/01/2023","start_date":" 06/01/2023","primary_txt":" Primary completion: 06/30/2025","primary_completion_date":" 06/30/2025","study_txt":" Completion: 06/30/2027","study_completion_date":" 06/30/2027","last_update_posted":"2024-04-03"},{"id":"ea1db548-3290-43ce-90b8-d7da0c14c574","acronym":"TIMAR1","url":"https://clinicaltrials.gov/study/NCT04904120","created_at":"2022-05-11T22:55:53.385Z","updated_at":"2024-07-02T16:35:30.189Z","phase":"Phase 1","brief_title":"Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy","source_id_and_acronym":"NCT04904120 - TIMAR1","lead_sponsor":"Viewpoint Molecular Targeting","biomarkers":" MC1R","pipe":"","alterations":" ","tags":["MC1R"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e VMT-01"],"overall_status":"Completed","enrollment":" Enrollment 7","initiation":"Initiation: 03/05/2021","start_date":" 03/05/2021","primary_txt":" Primary completion: 09/20/2022","primary_completion_date":" 09/20/2022","study_txt":" Completion: 09/20/2022","study_completion_date":" 09/20/2022","last_update_posted":"2023-11-07"}]